Results 151 to 160 of about 636,610 (341)
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson+11 more
wiley +1 more source
Toward a Resolution of the Discrepancy between Different Estimators of Star Formation Rate [PDF]
Andrew Hopkins+3 more
openalex +1 more source
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source
The H i Reservoir in Central Spiral Galaxies and the Implied Star Formation Process
The cold interstellar medium (ISM) as the raw material for star formation is critical to understanding galaxy evolution. It is generally understood that galaxies stop making stars when, in one way or another, they run out of gas. However, here we provide
Jing Dou+16 more
doaj +1 more source
Effect of Dust Extinction on Estimating the Star Formation Rate of Galaxies: Lyman Continuum Extinction [PDF]
Akio Inoue+2 more
openalex +1 more source
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani+14 more
wiley +1 more source
Cosmic Star Formation Rate at z ~ 3 — Metallicity Effect [PDF]
Hiroyuki Hirashita+2 more
openalex +1 more source
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source
Star formation quenching is one of the key processes that shape the evolution of galaxies. In this study, we investigate the changes in molecular gas and star formation properties as galaxies transit from the star-forming main sequence to the passive ...
Hsi-An Pan+9 more
doaj +1 more source
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen+12 more
wiley +1 more source